Check Elevance Health, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$69.8B
EPS (TTM)
29.8818
Dividend Yield
1.12%
Quarterly Earnings Growth YOY
-0.22%
PE Ratio (TTM)
13.16
Industry PE ratio
16.65525641025641
P/B Ratio
13.1579
PEG Ratio
0.7981
EBITDA
9.5B
Revenue (TTM)
189.3B
Profit Margin
2.83%
Return On Equity TTM
12.42%
Track how Elevance Health, Inc P/E has moved over time to understand its valuation trends.
Elevance Health, Inc in the last 5 years
Lowest (11.70x)
March 31, 2025
Today (13.16x)
September 18, 2025
Industry (16.66x)
September 18, 2025
Highest (17.48x)
December 31, 2022
Today’s Price to Earnings Ratio: 13.16x
Compare market cap, revenue, PE, and other key metrics of Elevance Health, Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $69.8B | NA | 13.16 | 2.83% | |
BUY | $79.2B | 76.63% | 16.26 | 1.92% | |
BUY | $93.9B | 24.22% | 20.61 | 1.18% | |
BUY | $309.4B | 10.91% | 14.79 | 5.04% | |
BUY | $32.4B | -33.09% | 20.66 | 1.28% |
The Elevance Health, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Elevance Health, Inc investment value today
Current value as on today
₹63,341
Returns
Returns from Elevance Health, Inc Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 26 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 26 analysts, 84.62% of analysts recommend a 'BUY' rating for Elevance Health, Inc. Average target price of $370.44
Get share price movements and forecasts by analysts on Elevance Health, Inc.
What analysts predicted
14.97%UPSIDE
Target Price
$370.44
Current Price
$314.98
Analyzed by
26 Analysts
Target
$370.44
Elevance Health, Inc target price $370.44, a slight upside of 14.97% compared to current price of $314.98. According to 26 analysts rating.
Investment in Elevance Health, Inc Shares on INDmoney has dropped by -54.73% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Elevance Health, Inc Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Elevance Health, Inc. has demonstrated consistent revenue growth over the last six quarters. The company's revenue increased from $42.57 billion to $49.77 billion, averaging an increase of 3.1% per quarter.
Against Peers
In the last 3 years, Elevance Health, Inc has experienced a drawdown of -35.8%, however The Cigna Corp resisted the overall trend and outperformed by 8.3%
Against Peers
In the last 1 year, Cvs Health Corporation has given 26.7% return, outperforming this stock by 69.5%
Profit Down
Elevance Health, Inc. has experienced a decline in its net profit over the last two quarters. In the first quarter, the net profit was $2.18 billion, which decreased to $1.74 billion in the second quarter. This represents an average decrease of 20.2% per quarter.
Price Dip
In the last 3 months, ELV stock has moved down by -17.9%
Organisation | Elevance Health, Inc |
Headquarters | 220 Virginia Avenue, Indianapolis, IN, United States, 46204 |
Industry | Healthcare |
CEO | Ms. Gail Koziara Boudreaux |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Ronald William Penczek | Senior VP, Controller & Chief Accounting Officer |
Mr. Nathan Allen Rich | Vice President of Investor Relations |
Mr. Peter David Haytaian Esq. | Executive VP and President of Carelon & CarelonRx |
Mr. Scott Wayne Anglin | SVP, Treasurer & Chief Investment Officer |
Mr. Charles Morgan Kendrick Jr. | Executive VP & President of Commercial Health Benefits |
Ms. Felicia Farr Norwood | Executive VP & President of Government Health Benefits |
Mr. Blair Williams Todt | Executive VP and Chief Legal & Administrative Officer |
Ms. Julie Goon | Senior Vice President of Public Affairs |
Ms. Gail Koziara Boudreaux | President, CEO & Director |
Mr. Mark Bradley Kaye | Executive VP & CFO |
Elevance Health, Inc share price today is $314.98 as on . Elevance Health, Inc share today touched a day high of $316.5 and a low of $307.96.
Elevance Health, Inc share touched a 52 week high of $544.6 on and a 52 week low of $273.71 on . Elevance Health, Inc stock price today i.e. is trending at $314.98,which is 42.16% down from its 52 week high and 15.08% up from its 52 week low.
Elevance Health, Inc market capitalisation is $0.07T as on .
Indian investors can start investing in Elevance Health, Inc (ELV) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Elevance Health, Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Elevance Health, Inc share’s latest price of $314.98 as on September 19, 2025 at 12:42 am IST, you will get 0.0317 shares of Elevance Health, Inc. Learn more about
fractional shares .